26 filings · most recent first
EXAS 8-K Filings
Exact Sciences Merged With Abbott Delisted From Nasdaq
Exact Sciences To Merge With Abbott Laboratories
Exact Sciences Shareholders Approve Merger With Abbott Laboratories
Exact Sciences Announces Updated Financial Projections For Merger With Abbott
Exact Sciences Reports Strong Q4 And Fullyear 2025 Results And Announces
Exact Sciences Announces Executive Compensation Adjustments Ahead Of Merger
Abbott To Acquire Exact Sciences In 21 Billion Deal
Exact Sciences Reports Strong Third Quarter 2025 Results
Exact Sciences Announces Second Quarter 2025 Results And Strategic
Exact Sciences Approves Incentive Plans And Shareholder Votes At 2025 Annual
Exact Sciences Announces Strong Q1 2025 Results And Raises Guidance
Exact Sciences Appoints New Board Member Leslie Trigg
Exact Sciences Reports 2024 Revenue And Fourth Quarter Results
Exact Sciences Announces Preliminary Financial Results And New Credit Agreement
Exact Sciences Appoints Kim Popovits To Board Of Directors
Exact Sciences Announces Thirdquarter 2024 Financial Results Revenue Growth And
Exact Sciences Reports Q2 2024 Results With Record Revenue And Adjusted Ebitda
Exact Sciences Announces 2024 Annual Meeting Shareholder Approvals
Exact Sciences Announces Leadership Changes And Reiterates Financial Guidance
Exact Sciences Files Prospectus Supplement For Share Resale
Exact Sciences Announces Firstquarter 2024 Financial Results
Dr Freda Lewishall To Retire From Exact Sciences Board
Exact Sciences Completes Debt Exchange Transaction
Exact Sciences Appoints Aaron Bloomer As New Cfo
Exact Sciences Announces Record Revenue And Positive Free Cash Flow For Q4 2023
Exact Sciences Announces Preliminary Q4 2023 Results And Cfo Succession Plan